Vir Biotechnology Inc (VIR)

Exchange
NASDAQ
Symbol
VIR
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Country
USA

Stock price

At close: February 5, 2026

  • Open
    7.35
  • High
    7.50
  • Low
    6.86
  • Close
    6.92
  • Volume
    1,267,340

Financial ratios

Dec 31, 2024